Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Clinical Lymphoma & Myeloma|December 17, 2009
The chronic myeloid leukemia stem cellEmma Nicholson, Tessa HolyoakeCancers|November 11, 2022
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication TherapyEduardo Gómez-Castañeda, Lisa E M Hopcroft, Simon Rogers, et al.Seminars in Cancer Biology|August 6, 2017
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic optionsSteffen Koschmieder, David VetrieLeukemia & Lymphoma|June 30, 2004
Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemiaMark Drummond, Anne Lennard, Tim Brûmmendorf, et al.Human Molecular Genetics|September 11, 2004
Applications of genomic microarrays to explore human chromosome structure and functionNigel P Carter, David VetrieBlood|February 5, 2017
The chronic myeloid leukemia stem cell: stemming the tide of persistenceTessa L Holyoake, David VetriePakistan Journal of Pharmaceutical Sciences|July 1, 2011
Analysis of imatinib in bone marrow and plasma samples of chronic myeloid leukaemia patients using solid phase extraction LC-ESI-MSZafar Iqbal, Moira Elliott, David G Watson, et al.Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
Proceedings of the Third Global Workshop on Chronic Myeloid LeukemiaGiuseppe Saglio, Hagop Kantarjian, Tessa Holyoake, et al.Plos Computational Biology|September 15, 2009
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinibJasmine Foo, Mark W Drummond, Bayard Clarkson, et al.Nature Reviews. Cancer|January 8, 2020
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AMLDavid Vetrie, G Vignir Helgason, Mhairi CoplandPageof 5